Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 10, 1999, Pages 1110-1113

  Di Rienzo, V ^a   Pagani, A ^b   Parmiani, S ^b   Passalacqua, G ^c   Canonica, G W ^c,d  

^a Clinica Villa Benedetta   (Italy)

^b Ospiate di Bollate ^*  (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d DIMI   (Italy)

Author keywords

Pediatric patients; Safety; Side effects; Sublingual immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; POLLEN ANTIGEN;

ABDOMINAL PAIN; ADOLESCENT; ALTERNARIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; DESENSITIZATION; EYE IRRITATION; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT ALLERGY; RHINITIS; SUBLINGUAL DRUG ADMINISTRATION; URTICARIA;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; RESPIRATORY HYPERSENSITIVITY; TIME FACTORS;

EID: 0032822961     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00267.x     Document Type: Article

References (20)

1. Jacobsen L, Dreborg S, Moller C, et al. Immunotherapy as preventive treatment. J Allergy Clin Immunol 1996;97:232.
2. Des Roches A, Paradis A, Menardo JL, Bouges R, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides extract. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450-453.
3. WHO Position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Bousquet J, Lockey RF, Mailing H-J, editors. Allergy 1998:53 Suppl 44.
4. Malling H-J, Abreu-Nogueira J, Alvarez-Cuesta E, et al. EAACI/ESPACI Position paper on local immunotherapy. Allergy 1998;53:833-844.
5. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol (Madr) 1990;18:277-284.
6. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:173-178.
7. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994,49:309-313.
8. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double blind study. J Investig Allergol Clin Immunol 1995;5:25-30.
9. Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-632.
10. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy. A double-blind, placebo-controlled trial of a standardized five-grasspollen extract in rhinitis. Allergy 1998;53:493-498.
11. Horak F, Stubner UE, Berger U, Marks B, Toth J, Jäger S. Immunotherapy with sublingual birch pollen extract: a short term double blind study. J Investig Allergol Clin Immunol 1998;8:165-171.
12. Gozalo F, Martin S, Rico P, Alvarez E, Cortes C. Clinical efficacy and tolerance of two years' Lolium perenne sublingual immunotherapy. Allergol Immunopathol (Madr) 1997;25:219-227.
13. Purello d'Ambrosio F, Ricciardi L, Isola S, et al. Rush sublingual immunotherapy in Parietaria allergic patients. Allergol Immunopathol (Madr) 1996;21:146-151.
14. Quirino T, Iemoli B, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients. A double blind double dummy study. Clin Exp Allergy 1996;26:1253-1261.
15. Vourdas D, Syrigou E, Potamianou B, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:661-672.
16. Hirsch T, Shan M, Leupold W. Double blind placebo controlled study of sublingual immunotherapy with house dust mite extract (D pt) in children. Pediatr Allergy Immunol 1997;8:21-27.
17. Carreira J, Rubio M, Herrero T, et al. Collaborative clinical assay of the biological potency of allergen skin test extracts. Clin Allergy 1984;14:503-507.
18. Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Arbeiten aus dem Paul Ehrlich Institut. Stuttgart: Gustav Fischer Verlag, 1994.
19. Almagro E, Asensio O, Bartolomé JM, et al. Estudio multicentrico de farmacovigilancia de inmunoterapia sublingual en pacientes alergicos. Allergol Immunopathol (Madr) 1995;23:153-159.
20. Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55-62.